Displaying items by tag: Science

Thursday, 24 November 2022 21:18

COP27: climate deal and disappointments

Luke-warm applause met a historic moment when a ‘loss and damage fund’ was agreed in the early hours of 20 November 20 after a confusing and often chaotic 48 hours left delegates exhausted. This fund will see developed nations paying poorer countries for damage and economic losses caused by climate change, ending almost thirty years of waiting by poorer nations experiencing huge climate impacts. But there was disappointment over the lack of progress on cutting fossil fuels. ‘A clear commitment to phase-out all fossil fuels? Not in this text,’ said the UK's president of the Glasgow COP26 summit. The final overarching deal did not include commitments to ‘phase down’ or reduce use of fossil fuels. It also included ambiguous new languages about ‘low emissions energy’ - which experts say could open the door to some fossil fuels being considered part of a green energy future.

Published in Worldwide
Friday, 13 May 2022 09:21

Pakistan: vaccination campaign stalling

Health workers in Pakistan are marking children’s fingers as having had a polio vaccination, when in reality parents have refused the vaccine after believing conspiracy theories that they are harmful, blasphemous, or a plot to sterilise Muslims. This is the biggest challenge - to eradicate the crippling virus in one of its last haunts. Deteriorating security along the border is making the situation worse, as militants cross from Afghanistan - the only other country where polio is still circulating. After two years free of polio Pakistan has two poliovirus cases. They were also paralysed, raising further concerns that there may still be hundreds of cases in the region. On average, only one in 200 infections leads to paralysis. Bill Gates, who invests billions in the polio fight, said ‘it would be tragic if the disease made a comeback because it would spread back across the world and eventually you have what you had before 1988 - hundreds of thousands of paralysed children.’

Published in Worldwide
Wednesday, 15 December 2021 21:31

Needle-free coronavirus vaccine enters clinical trial

Safety trials are underway for a Cambridge-led vaccine that could be used as a booster targeting Covid variants which threaten future coronavirus pandemics. The first volunteer received the vaccine on 14 December through a needle-free ‘injection’ - a blast of air that delivers it into the skin. This offers a possible future alternative to people who fear needle-based jabs. If it is successful it could be scaled up and manufactured as a powder to boost global vaccination efforts, particularly in low and middle-income countries. As new variants emerge there is a need for newer technologies. It’s vital that science continues to develop new generation vaccines. Pray for this new trial to lead the way for vaccines that will prime the immune system to respond with broader, stronger protection. The vaccine trial will follow up volunteers for about a year to ensure it is safe.

Published in British Isles
Thursday, 09 December 2021 20:37

Pandemic: Omicron reinfection

WHO chief scientist Dr Swaminathan said reinfections with the Omicron variant 90 days after the virus first strikes are three times more common. While data on the virulence and transmissibility will take time, scientists know that Omicron is a dominant strain in South Africa. They have said there was no surge of re-infection during either the Beta or Delta waves, despite laboratory studies suggesting those variants had the potential to evade some immunity. But they are now detecting a spike in re-infections and the timing suggests the Omicron variant is the driving force. Prof Juliet Pulliam, from Stellenbosch University, said, ‘These findings suggest that Omicron's selection advantage is at least partially driven by an increased ability to infect previously infected individuals.’ However, it is still only one piece of the puzzle. See

Published in Worldwide
Thursday, 11 November 2021 21:48

Covid gene doubling death risk

British scientists have identified a gene that doubles the risk of dying from Covid-19, opening up possibilities for targeted medicine and providing new insights into why some people are more susceptible to the disease than others. Researchers at Oxford University found that 60% of people with South Asian ancestry carry the high-risk gene. The discovery partly explains the high number of deaths seen in some British communities, and the effect of Covid in the Indian subcontinent. The scientists found that the increased risk is not because of a difference in genetic coding of the proteins, but because of differences in the DNA that makes a kind of ‘switch’ to turn a gene on. That genetic signal is likely to affect cells in the lung. The study shows that the way in which the lung responds to the infection is critical. This is important because most treatments have focused on changing the way in which the immune system reacts to the virus.

Published in British Isles
Thursday, 26 August 2021 20:31

Taiwan: homegrown vaccine criticised

Taiwan is administering its domestically developed Covid-19 vaccine, amid criticism that its approval was rushed. The Medigen vaccine had not completed phase three trials when it was granted emergency approval by regulators. Medigen said there were no major safety concerns, and antibodies created were no worse than AstraZeneca's vaccine. It is expected to complete the final round of trials being held in Paraguay later this year. Taiwan's vaccination efforts have been hampered by delivery delays and hesitancy amongst its population. President Tsai Ing-wen led the way in receiving the Medigen jab on 23 August. The objections have mainly come from the opposite political party, the Kuomintang, who say it is unsafe. More than 700,000 people have already signed up for the vaccine, which requires two doses 28 days apart. Less than 5% of Taiwan's population is fully vaccinated: around 40% have received just one dose.

Published in Worldwide
Friday, 30 July 2021 10:24

Increasing city floods

There is more flash flooding, partly caused by climate change. Parts of London and the south of England were left under water and roads became impassable this week. Just 30cm of water is enough to move a car. Infrastructure and transport networks were damaged. London hospitals asked patients to stay away after they lost power. Urban areas experience ‘surface water’ flooding because they have a lot of hard surfaces - paved front gardens, car parks, roads and high streets. On 28 July several towns in Scotland were flooded, with more to come. https://www.bbc.co.uk/news/uk-scotland-57970845 Reading University says urban areas could benefit from permeable pavements and green roofs which can help rainwater to soak away rather than causing floods. Weather and flood forecasting has improved rapidly, and it is now possible to forecast surface water flooding events in advance.

Published in British Isles
Friday, 09 July 2021 10:05

Scientists in congregations

Church and science can seem like separate worlds, but many scientists appear in pews and pulpits across the UK. ‘Encouraging Christian Leadership in an Age of Science’ (ECLAS) affirms the work of faith-filled scientists who bring their vocation in science to the church, as members and active friends of congregations. ECLAS want to help them create spaces of engagement, build confidence and competence around scientific issues, and foster thoughtful, prayerful communities working in the world. They are funding 22 churches in England and Wales creatively to change the conversation between the church and the scientific world, focussing on topics from climate change to mental health, with the aim of showing how engaging with science can lead to a deeper experience of faith. ECLAS are supported by a grant of £400,000 to enable congregations and organisations to host these projects and shepherd follow-up projects for one or more additional congregations by 2022.

Published in British Isles
Thursday, 03 June 2021 21:13

Covid third wave and new variant

Scientist and government advisor Prof Ravi Gupta sees signs of early stages of a third wave. Although new cases are ‘relatively low’, the Indian variant spreads faster than the winter variant. All waves start with low numbers grumbling in the background before infections explode. New infections with the Indian variant are rising daily in both the north and south of England. Very few hospital patients have had two jabs. See Also an evolved version of the Indian strain, 'Nepal' Covid, has so far been found in twenty Britons. It is closely related to the Indian variant, but has new mutations. The Nepal variant has also spread to several European countries. Its detection in Portugal could put their green-list status at risk. SAGE experts warn that the UK cannot panic every time it spots a new strain. The Government is waiting for more data before making a final decision on whether restrictions will be lifted in England on 21 June. That decision will be announced on 14 June.

Published in British Isles
Thursday, 03 June 2021 20:43

USA: grow babies and kill them for research

An international group of scientists has ditched ethical guidelines so that they can grow babies for forty days, for the sole purpose of killing them for research. The International Society for Stem Cell Research issued new guidelines that lift restrictions on certain types of unethical research that manipulate, alter, or destroy human embryos. It wants to remove a 14-day rule for research on human embryos, established in 1979, which stated scientists may only experiment on human embryos up to 14 days after fertilisation. This rule has been the current policy in the United States and generally a scientific standard throughout the world. The new guidelines have removed all restraint, creating the potential for ‘baby in a bottle’ experiments. It also wants to use three-parent human embryos (human embryo with DNA from three individuals), which is currently prohibited, and to allow creating a cell from animal and human cells, characteristic, or tissues.

Published in Worldwide
Page 1 of 3